MaxLinear (MXL) Financials

$11.57 -0.50 (-4.14%)

Closing price 04:00 PM Eastern

Extended Trading

$11.89 +0.32 (+2.77%)

As of 07:04 PM Eastern

Annual Income Statements for MaxLinear

This table shows MaxLinear's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-245	-73	125	42	-99	-20	-26	-9.19	61	-42	-7.04
Consolidated Net Income / (Loss)	-245	-73	125	42	-99	-20	-26	-9.19	61	-20	-7.04
Net Income / (Loss) Continuing Operations	-245	-73	125	42	-99	-20	-26	-9.19	61	-20	-7.04
Total Pre-Tax Income	-239	-64	174	48	-115	-32	-33	-34	64	-43	-8.75
Total Operating Income	-223	-38	180	65	-101	-22	-19	-22	63	-44	-8.86
Total Gross Profit	195	386	650	496	213	168	209	208	230	155	82
Total Revenue	361	693	1,120	892	479	317	385	420	388	300	133
Operating Revenue	361	693	1,120	892	479	317	385	420	388	300	133
Total Cost of Revenue	166	308	470	397	266	149	176	212	158	145	51
Operating Cost of Revenue	166	308	470	397	266	149	176	212	158	145	51
Total Operating Expenses	418	424	470	431	314	190	228	230	167	199	91
Selling, General & Admin Expense	138	132	168	150	130	89	102	106	64	78	34
Research & Development Expense	225	270	296	278	180	98	120	112	98	85	57
Impairment Charge	1.24	2.44	2.81	0.00	0.09	0.00	2.20	2.00	1.30	0.00	0.00
Restructuring Charge	53	20	2.27	2.20	3.83	2.64	3.84	9.52	3.43	14	0.00
Total Other Income / (Expense), net	-15	-26	-6.05	-17	-14	-10	-14	-12	0.63	1.49	0.11
Interest Expense	11	11	9.77	18	13	11	14	10	0.10	0.10	-
Interest & Investment Income	6.39	6.05	0.25	0.08	0.41	0.78	0.08	0.27	0.57	0.28	0.24
Other Income / (Expense), net	-11	-21	3.48	0.76	-1.17	-0.07	0.42	-2.22	0.16	1.31	-0.12
Income Tax Expense	6.48	9.34	49	5.90	-16	-13	-6.65	-25	2.40	-0.58	-1.70
Basic Earnings per Share	($2.93)	($0.91)	$1.60	$0.55	($1.35)	($0.28)	($0.38)	($0.14)	$0.96	($0.79)	($0.19)
Weighted Average Basic Shares Outstanding	83.60M	80.72M	78.04M	76.04M	73.13M	71.01M	68.49M	66.25M	63.78M	53.38M	36.47M
Diluted Earnings per Share	($2.93)	($0.91)	$1.55	$0.53	($1.35)	($0.28)	($0.38)	($0.14)	$0.91	($0.79)	($0.19)
Weighted Average Diluted Shares Outstanding	83.60M	80.72M	80.85M	79.68M	73.13M	71.01M	68.49M	66.25M	67.65M	53.38M	36.47M
Weighted Average Basic & Diluted Shares Outstanding	84.63M	81.93M	78.75M	76.78M	74.54M	71.95M	71.95M	65.60M	63.80M	53.60M	37.10M

This table shows MaxLinear's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-50	-58	-76	-39	-72	-39	-40	-4.35	9.53	31	28
Consolidated Net Income / (Loss)	-50	-58	-76	-39	-72	-39	-40	-4.35	9.53	31	28
Net Income / (Loss) Continuing Operations	-50	-58	-76	-39	-72	-39	-40	-4.35	9.53	31	28
Total Pre-Tax Income	-49	-41	-82	-41	-74	-43	-42	-4.76	25	41	45
Total Operating Income	-46	-41	-67	-41	-75	-42	-18	-5.94	27	41	52
Total Gross Profit	54	51	44	50	49	69	74	103	140	163	167
Total Revenue	96	92	81	92	95	125	136	184	248	291	286
Operating Revenue	96	92	81	92	95	125	136	184	248	291	286
Total Cost of Revenue	42	41	37	42	46	57	62	81	108	127	118
Operating Cost of Revenue	42	41	37	42	46	57	62	81	108	127	118
Total Operating Expenses	100	92	111	91	124	110	92	109	113	122	116
Selling, General & Admin Expense	37	38	30	34	36	34	25	34	39	44	38
Research & Development Expense	55	51	53	57	65	65	66	71	67	74	76
Restructuring Charge	7.88	3.06	27	0.87	23	11	0.05	4.44	4.65	1.17	0.63
Total Other Income / (Expense), net	-2.91	0.35	-16	-0.51	0.55	-0.89	-24	1.18	-2.18	-0.45	-7.35
Interest Expense	2.50	2.80	2.66	2.71	2.71	2.91	2.72	2.59	2.49	2.29	2.71
Interest & Investment Income	0.86	1.04	1.65	1.87	1.82	1.78	1.74	1.90	0.63	0.07	0.06
Other Income / (Expense), net	-1.27	2.11	-15	0.33	1.43	0.24	-23	1.87	-0.32	1.77	-4.71
Income Tax Expense	0.71	17	-6.71	-2.06	-1.76	-4.13	-1.69	-0.41	16	9.63	16
Basic Earnings per Share	($0.58)	($0.68)	($0.90)	($0.47)	($0.88)	($0.49)	($0.49)	($0.05)	$0.12	$0.39	$0.36
Weighted Average Basic Shares Outstanding	85.27M	83.60M	84.07M	83.48M	82.35M	80.72M	81.25M	80.45M	79.47M	78.04M	78.44M
Diluted Earnings per Share	($0.58)	($0.68)	($0.90)	($0.47)	($0.88)	($0.49)	($0.49)	($0.05)	$0.12	$0.38	$0.35
Weighted Average Diluted Shares Outstanding	85.27M	83.60M	84.07M	83.48M	82.35M	80.72M	81.25M	80.45M	81.34M	80.85M	80.06M
Weighted Average Basic & Diluted Shares Outstanding	86.37M	84.63M	84.36M	83.90M	83.13M	81.93M	81.56M	81.02M	79.98M	78.75M	78.57M

This table details how cash moves in and out of MaxLinear's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-69	-0.00	57	-18	57	19	-0.22	-8.48	15	47	-5.75
Net Cash From Operating Activities	-45	43	389	168	74	78	103	75	117	55	12
Net Cash From Continuing Operating Activities	-45	43	389	168	74	78	103	75	117	55	12
Net Income / (Loss) Continuing Operations	-245	-73	125	42	-99	-20	-26	-9.19	61	-42	-7.04
Consolidated Net Income / (Loss)	-245	-73	125	42	-99	-20	-26	-9.19	61	-42	-7.04
Depreciation Expense	54	72	81	92	77	66	79	67	27	41	5.11
Amortization Expense	2.54	2.56	1.98	3.00	2.20	1.58	1.15	26	5.81	15	0.72
Non-Cash Adjustments To Reconcile Net Income	79	62	71	59	77	24	32	27	15	50	15
Changes in Operating Assets and Liabilities, net	65	-20	109	-28	16	6.32	17	-36	8.16	-7.94	-1.59
Net Cash From Investing Activities	-23	-16	-92	-92	-175	-6.97	-7.83	-432	-101	-11	-17
Net Cash From Continuing Investing Activities	-23	-16	-92	-92	-175	-6.97	-7.83	-432	-101	-11	-17
Purchase of Property, Plant & Equipment	-18	-13	-41	-39	-12	-6.89	-7.83	-7.47	-8.51	-3.00	-8.80
Acquisitions	-5.77	-20	-11	-48	-163	-0.09	0.00	-479	-101	-3.72	-9.14
Purchase of Investments	0.00	0.00	-29	-5.00	0.00	0.00	0.00	-31	-90	-73	-57
Sale and/or Maturity of Investments	0.00	17	0.00	0.00	-	-	0.00	85	99	69	57
Other Investing Activities, net	0.00	0.00	-10	0.00	0.00	-	-	-	-	-	-
Net Cash From Financing Activities	1.29	-26	-240	-92	160	-53	-94	347	-0.67	4.00	-0.51
Net Cash From Continuing Financing Activities	1.29	-26	-240	-92	160	-53	-94	347	-0.67	4.00	-0.51
Repayment of Debt	0.00	-18	-185	-414	-20	-50	-93	-70	0.00	0.00	-
Repurchase of Common Equity	0.00	0.00	-32	-24	0.00	0.00	0.00	-0.33	-0.00	-0.81	0.00
Issuance of Common Equity	4.09	4.56	5.01	8.78	8.07	8.60	6.84	12	6.65	9.95	3.30
Other Financing Activities, net	-2.81	-13	-29	-13	-3.54	-12	-7.62	-12	-7.32	-5.14	-3.81
Effect of Exchange Rate Changes	-1.30	-1.08	0.06	-2.87	-1.04	0.93	-1.30	1.58	-0.39	-0.73	-0.02
Cash Interest Paid	9.74	9.48	9.08	11	11	11	14	8.84	0.00	0.00	-
Cash Income Taxes Paid	8.19	29	24	3.84	2.82	4.42	5.43	9.44	1.58	0.04	0.19

This table details how cash moves in and out of MaxLinear's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-16	-30	-37	-6.79	4.57	0.20	-37	17	20	5.86	-30
Net Cash From Operating Activities	-11	-28	-31	-2.70	16	-17	-13	31	42	69	62
Net Cash From Continuing Operating Activities	-11	-28	-31	-2.70	16	-17	-13	31	42	69	62
Net Income / (Loss) Continuing Operations	-50	-58	-76	-39	-72	-39	-40	-4.35	9.53	31	28
Consolidated Net Income / (Loss)	-50	-58	-76	-39	-72	-39	-40	-4.35	9.53	31	28
Depreciation Expense	11	12	12	14	17	17	17	19	19	19	18
Amortization Expense	0.51	0.55	0.64	0.67	0.69	0.70	0.69	0.63	0.55	0.51	0.51
Non-Cash Adjustments To Reconcile Net Income	23	22	27	9.80	19	25	1.87	19	16	33	22
Changes in Operating Assets and Liabilities, net	3.82	-4.34	4.84	13	52	-21	7.47	-3.89	-2.66	-14	-7.20
Net Cash From Investing Activities	-1.99	-3.00	-5.95	-5.79	-8.71	15	-2.60	-13	-16	-17	-15
Net Cash From Continuing Investing Activities	-1.99	-3.00	-5.95	-5.79	-8.71	15	-2.60	-13	-16	-17	-15
Purchase of Property, Plant & Equipment	-1.99	-2.19	-4.13	-3.01	-8.34	-1.27	-1.93	-5.04	-5.22	-17	-9.12
Acquisitions	0.00	-0.81	-1.82	-2.78	-0.37	-1.10	-0.67	-7.61	-10	-0.74	-5.24
Net Cash From Financing Activities	-2.14	1.42	-0.06	2.03	-2.10	1.17	-21	0.11	-6.17	-49	-75
Net Cash From Continuing Financing Activities	-2.14	1.42	-0.06	2.03	-2.10	1.17	-21	0.11	-6.17	-49	-75
Issuance of Common Equity	-0.01	2.51	-	1.58	0.00	1.39	0.09	3.07	0.00	1.79	0.08
Other Financing Activities, net	-2.13	-1.09	-0.06	0.45	-2.10	-0.22	-3.23	-2.97	-6.17	-0.37	-0.38
Effect of Exchange Rate Changes	-0.01	-0.47	0.09	-0.34	-0.58	0.78	-0.63	-1.23	0.00	2.46	-1.04
Cash Interest Paid	2.15	2.30	2.49	2.47	2.48	2.50	2.48	2.34	2.16	2.16	2.64
Cash Income Taxes Paid	1.23	-1.28	6.05	2.06	1.36	3.31	11	11	3.34	9.75	4.61

This table presents MaxLinear's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	865	1,080	1,180	1,050	1,022	706	744	825	423	335	136
Total Current Assets	323	488	563	404	362	182	185	201	213	190	101
Cash & Equivalents	119	187	187	131	149	93	73	72	81	68	21
Restricted Cash	1.00	1.05	0.98	0.11	0.12	0.35	0.65	1.48	0.61	-	-
Accounts Receivable	85	171	171	120	67	50	59	66	50	42	19
Inventories, net	90	100	161	132	98	32	42	53	27	32	11
Prepaid Expenses	28	29	25	22	47	6.79	10	8.42	6.16	3.90	2.44
Plant, Property, & Equipment, net	59	66	79	61	39	17	18	23	21	22	12
Total Noncurrent Assets	482	526	538	585	621	507	540	601	189	123	25
Goodwill	319	319	307	307	303	238	238	238	76	50	1.20
Intangible Assets	55	74	109	153	207	188	245	315	104	51	13
Noncurrent Deferred & Refundable Income Taxes	69	69	66	89	86	67	52	40	0.12	-	-
Other Noncurrent Operating Assets	40	64	55	36	24	14	4.66	6.92	1.68	2.27	0.51
Other Noncurrent Nonoperating Assets	0.03	0.02	0.02	1.06	1.02	0.06	0.40	1.06	1.20	-	-
Total Liabilities & Shareholders' Equity	865	1,080	1,180	1,050	1,022	706	744	825	423	335	136
Total Liabilities	348	394	504	561	631	291	344	437	70	72	37
Total Current Liabilities	182	222	341	207	234	67	75	76	55	56	33
Accounts Payable	31	22	69	53	33	13	16	17	6.76	6.39	7.51
Accrued Expenses	131	170	213	98	154	44	45	42	32	35	16
Current Employee Benefit Liabilities	20	30	59	57	47	9.39	15	13	10	9.98	6.56
Total Noncurrent Liabilities	166	172	163	354	398	224	268	361	16	16	3.36
Long-Term Debt	123	122	122	306	364	207	256	348	0.00	-	-
Other Noncurrent Operating Liabilities	43	49	41	48	34	17	13	8.56	6.03	4.32	1.19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	516	686	676	489	391	415	400	387	352	263	99
Total Preferred & Common Equity	516	686	676	489	391	415	400	387	352	263	99
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	516	686	676	489	391	415	400	387	352	263	99
Common Stock	887	809	723	657	602	530	493	456	414	385	178
Retained Earnings	-364	-119	-45	-170	-212	-114	-94	-69	-60	-121	-79
Accumulated Other Comprehensive Income / (Loss)	-6.82	-3.79	-1.02	2.13	1.44	-0.89	0.27	1.04	-1.56	-0.82	-0.03

This table presents MaxLinear's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	855	895	973	1,031	1,104	1,161	1,198	1,183
Total Current Assets	320	328	398	445	509	554	594	563
Cash & Equivalents	103	148	185	192	187	225	208	181
Restricted Cash	1.27	0.99	1.01	1.03	1.11	1.04	0.96	0.97
Accounts Receivable	99	48	85	126	158	156	189	178
Inventories, net	86	96	95	96	115	126	150	166
Prepaid Expenses	31	35	32	29	33	26	28	18
Plant, Property, & Equipment, net	56	63	65	68	69	74	78	67
Total Noncurrent Assets	479	504	510	518	526	533	527	553
Goodwill	319	319	319	319	318	318	319	307
Intangible Assets	52	58	62	65	83	91	96	122
Noncurrent Deferred & Refundable Income Taxes	69	83	74	72	59	57	58	66
Other Noncurrent Operating Assets	40	44	56	62	65	67	54	58
Other Noncurrent Nonoperating Assets	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.03
Total Liabilities & Shareholders' Equity	855	895	973	1,031	1,104	1,161	1,198	1,183
Total Liabilities	362	338	356	393	401	415	464	567
Total Current Liabilities	197	169	190	224	233	242	300	351
Accounts Payable	18	31	36	32	45	46	55	91
Accrued Expenses	155	116	133	163	158	171	217	211
Current Employee Benefit Liabilities	24	22	22	28	30	25	29	49
Total Noncurrent Liabilities	165	170	166	169	168	174	164	215
Long-Term Debt	123	123	123	123	122	122	122	172
Other Noncurrent Operating Liabilities	42	47	43	46	46	52	42	44
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	493	557	617	638	703	746	734	616
Total Preferred & Common Equity	493	557	617	638	703	746	734	616
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	493	557	617	638	703	746	734	616
Common Stock	913	867	854	834	791	789	771	698
Retained Earnings	-413	-306	-230	-191	-80	-40	-36	-76
Accumulated Other Comprehensive Income / (Loss)	-5.97	-3.85	-6.52	-5.57	-7.94	-2.29	-1.21	-5.32

This table displays calculated financial ratios and metrics derived from MaxLinear's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-48.00%	-38.12%	25.53%	86.46%	50.89%	-17.61%	-8.40%	8.38%	29.12%	125.64%	11.25%
EBITDA Growth	-1,290.34%	-94.40%	65.69%	781.50%	-151.46%	-25.44%	-11.00%	-27.82%	630.75%	515.90%	59.94%
EBIT Growth	-295.92%	-132.20%	178.33%	164.52%	-362.39%	-18.48%	21.84%	-137.79%	249.33%	-371.42%	28.46%
NOPAT Growth	-484.37%	-120.68%	126.18%	180.80%	-358.53%	-15.50%	11.88%	-125.00%	298.61%	-392.76%	28.28%
Net Income Growth	-235.21%	-158.50%	197.93%	142.57%	-395.49%	24.05%	-185.17%	-114.99%	406.64%	-183.88%	44.70%
EPS Growth	-221.98%	-158.71%	192.45%	139.26%	-382.14%	26.32%	-171.43%	-115.38%	215.19%	-315.79%	48.65%
Operating Cash Flow Growth	-204.43%	-88.84%	131.06%	128.60%	-6.07%	-23.70%	36.80%	-36.02%	113.14%	349.90%	-5.09%
Free Cash Flow Firm Growth	0.08%	-127.65%	11,721.82%	98.82%	-492.93%	-43.19%	114.29%	-1,944.46%	83.94%	-388.00%	-379.59%
Invested Capital Growth	-16.22%	4.91%	-10.90%	9.75%	14.37%	-9.08%	-11.98%	206.38%	62.82%	479.87%	7,036.56%
Revenue Q/Q Growth	-8.43%	-19.25%	3.96%	6.34%	35.24%	-5.26%	-6.35%	6.75%	-2.96%	28.42%	0.68%
EBITDA Q/Q Growth	-1.48%	-85.29%	2.56%	53.89%	-63.33%	-1.03%	-19.45%	7.04%	21.92%	59.17%	-62.79%
EBIT Q/Q Growth	1.03%	-334.05%	7.04%	502.44%	-18.24%	8.51%	-27.46%	-168.93%	34.74%	-8.11%	-26.99%
NOPAT Q/Q Growth	0.25%	-227.90%	1.87%	566.92%	-18.42%	11.21%	-35.91%	-182.06%	38.42%	-10.59%	-26.83%
Net Income Q/Q Growth	-8.56%	-1,950.66%	2.38%	485.78%	-20.20%	-73.28%	42.99%	-149.37%	-8.17%	44.71%	3.89%
EPS Q/Q Growth	-6.93%	-2,175.00%	1.97%	431.25%	-20.54%	-64.71%	42.42%	-151.85%	37.88%	-8.22%	5.00%
Operating Cash Flow Q/Q Growth	-33.10%	-66.46%	15.90%	-25.71%	168.28%	5.29%	2.42%	-7.24%	2.66%	122.70%	-41.25%
Free Cash Flow Firm Q/Q Growth	14.03%	-27.12%	31.33%	-102.55%	17.95%	57.05%	-23.02%	1.42%	9.55%	24.35%	-434.10%
Invested Capital Q/Q Growth	-1.99%	-0.30%	0.83%	8.25%	-10.09%	-4.47%	-2.21%	-4.24%	-5.62%	-17.10%	978.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.03%	55.63%	58.00%	55.56%	44.46%	52.87%	54.23%	49.48%	59.30%	51.75%	61.57%
EBITDA Margin	-49.25%	2.15%	23.78%	18.02%	-4.93%	14.46%	15.97%	16.44%	24.68%	4.36%	-2.37%
Operating Margin	-61.95%	-5.51%	16.09%	7.31%	-21.13%	-6.95%	-4.96%	-5.16%	16.26%	-14.53%	-6.65%
EBIT Margin	-64.97%	-8.53%	16.40%	7.40%	-21.38%	-6.98%	-4.85%	-5.68%	16.30%	-14.10%	-6.75%
Profit (Net Income) Margin	-68.01%	-10.55%	11.16%	4.70%	-20.60%	-6.27%	-6.81%	-2.19%	15.80%	-6.65%	-5.29%
Tax Burden Percent	102.71%	114.63%	71.78%	87.67%	85.84%	61.25%	79.75%	27.02%	96.23%	46.59%	80.51%
Interest Burden Percent	101.92%	107.86%	94.82%	72.52%	112.26%	146.81%	175.91%	142.29%	100.74%	101.34%	97.37%
Effective Tax Rate	0.00%	0.00%	28.22%	12.33%	0.00%	0.00%	0.00%	0.00%	3.77%	0.00%	0.00%
Return on Invested Capital (ROIC)	-27.43%	-4.42%	20.62%	9.02%	-12.49%	-2.78%	-2.15%	-3.46%	34.87%	-39.36%	-53.55%
ROIC Less NNEP Spread (ROIC-NNEP)	256.50%	56.99%	10.90%	1.17%	-29.48%	-5.80%	-7.80%	5.31%	34.42%	-49.58%	-52.52%
Return on Net Nonoperating Assets (RNNOA)	-13.35%	-6.32%	0.84%	0.51%	-11.97%	-2.10%	-4.50%	0.98%	-14.95%	28.32%	45.97%
Return on Equity (ROE)	-40.78%	-10.74%	21.46%	9.54%	-24.46%	-4.88%	-6.65%	-2.48%	19.92%	-11.04%	-7.58%
Cash Return on Invested Capital (CROIC)	-9.78%	-9.21%	32.15%	-0.27%	-25.90%	6.73%	10.59%	-105.03%	-12.93%	-180.52%	-248.03%
Operating Return on Assets (OROA)	-24.09%	-5.23%	16.47%	6.37%	-11.84%	-3.05%	-2.38%	-3.83%	16.70%	-18.01%	-6.89%
Return on Assets (ROA)	-25.21%	-6.47%	11.21%	4.05%	-11.41%	-2.75%	-3.34%	-1.47%	16.19%	-8.50%	-5.40%
Return on Common Equity (ROCE)	-40.78%	-10.74%	21.46%	9.54%	-24.46%	-4.88%	-6.65%	-2.48%	19.92%	-11.04%	-7.58%
Return on Equity Simple (ROE_SIMPLE)	-47.49%	-10.66%	18.49%	8.58%	-25.21%	-4.80%	-6.55%	-2.37%	17.39%	-7.60%	-7.10%
Net Operating Profit after Tax (NOPAT)	-156	-27	129	57	-71	-15	-13	-15	61	-31	-6.20
NOPAT Margin	-43.37%	-3.86%	11.55%	6.41%	-14.79%	-4.87%	-3.47%	-3.61%	15.65%	-10.17%	-4.66%
Net Nonoperating Expense Percent (NNEP)	-283.93%	-61.40%	9.72%	7.85%	16.98%	3.02%	5.64%	-8.77%	0.45%	10.22%	-1.03%
Return On Investment Capital (ROIC_SIMPLE)	-24.46%	-3.31%	16.21%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	45.97%	44.37%	42.00%	44.44%	55.54%	47.13%	45.77%	50.52%	40.70%	48.25%	38.43%
SG&A Expenses to Revenue	38.37%	19.06%	15.00%	16.80%	27.17%	27.98%	26.44%	25.18%	16.62%	25.96%	25.69%
R&D to Revenue	62.46%	38.87%	26.46%	31.20%	37.61%	31.01%	31.18%	26.71%	25.20%	28.43%	42.54%
Operating Expenses to Revenue	115.98%	61.14%	41.91%	48.25%	65.60%	59.82%	59.19%	54.63%	43.04%	66.28%	68.23%
Earnings before Interest and Taxes (EBIT)	-234	-59	184	66	-102	-22	-19	-24	63	-42	-8.98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-178	15	266	161	-24	46	62	69	96	13	-3.15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.23	2.83	3.94	11.83	7.24	3.66	3.03	4.57	3.99	3.45	2.79
Price to Tangible Book Value (P/TBV)	11.69	6.59	10.25	192.90	0.00	0.00	0.00	0.00	8.17	5.61	3.27
Price to Revenue (P/Rev)	4.63	2.80	2.38	6.48	5.92	4.79	3.15	4.21	3.63	3.02	2.08
Price to Earnings (P/E)	0.00	0.00	21.33	137.84	0.00	0.00	0.00	0.00	22.95	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	4.69%	0.73%	0.00%	0.00%	0.00%	0.00%	4.36%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.22	3.02	4.37	8.98	5.04	3.09	2.40	3.09	5.90	5.86	8.62
Enterprise Value to Revenue (EV/Rev)	4.64	2.70	2.31	6.68	6.37	5.15	3.63	4.86	3.28	2.59	1.48
Enterprise Value to EBITDA (EV/EBITDA)	0.00	125.55	9.69	37.07	0.00	35.60	22.70	29.57	13.28	59.28	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	14.06	90.30	0.00	0.00	0.00	0.00	20.11	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	19.96	104.20	0.00	0.00	0.00	0.00	20.95	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	43.18	6.64	35.43	41.40	20.84	13.59	27.22	10.84	14.11	16.09
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	12.80	0.00	0.00	43.71	21.23	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.24	0.18	0.18	0.63	0.93	0.50	0.64	0.90	0.00	0.00	0.00
Long-Term Debt to Equity	0.24	0.18	0.18	0.63	0.93	0.50	0.64	0.90	0.00	0.00	0.00
Financial Leverage	-0.05	-0.11	0.08	0.44	0.41	0.36	0.58	0.18	-0.43	-0.57	-0.88
Leverage Ratio	1.62	1.66	1.91	2.35	2.14	1.78	1.99	1.69	1.23	1.30	1.40
Compound Leverage Factor	1.65	1.79	1.81	1.71	2.41	2.61	3.50	2.40	1.24	1.32	1.37
Debt to Total Capital	19.24%	15.13%	15.26%	38.49%	48.18%	33.27%	39.01%	47.29%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.24%	15.13%	15.26%	38.49%	48.18%	33.27%	39.01%	47.29%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	80.76%	84.87%	84.74%	61.51%	51.82%	66.73%	60.99%	52.71%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.69	8.20	0.46	1.90	-15.41	4.51	4.16	5.03	0.00	0.00	0.00
Net Debt to EBITDA	-0.02	-4.42	-0.32	1.09	-9.09	2.48	2.96	3.97	0.00	0.00	0.00
Long-Term Debt to EBITDA	-0.69	8.20	0.46	1.90	-15.41	4.51	4.16	5.03	0.00	0.00	0.00
Debt to NOPAT	-0.79	-4.57	0.94	5.35	-5.14	-13.40	-19.13	-22.91	0.00	0.00	0.00
Net Debt to NOPAT	-0.02	2.47	-0.66	3.07	-3.03	-7.37	-13.61	-18.08	0.00	0.00	0.00
Long-Term Debt to NOPAT	-0.79	-4.57	0.94	5.35	-5.14	-13.40	-19.13	-22.91	0.00	0.00	0.00
Altman Z-Score	2.00	3.56	4.81	7.24	2.69	3.45	2.56	2.90	13.68	8.06	5.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.77	2.20	1.65	1.95	1.55	2.73	2.46	2.64	3.90	3.40	3.04
Quick Ratio	1.12	1.61	1.10	1.21	0.93	2.15	1.76	1.81	3.29	2.75	2.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-56	-56	202	-1.74	-147	37	66	-460	-23	-140	-29
Operating Cash Flow to CapEx	-256.19%	322.37%	942.30%	429.43%	589.36%	1,137.62%	1,312.32%	1,009.20%	1,378.25%	1,837.15%	139.02%
Free Cash Flow to Firm to Interest Expense	-5.13	-5.21	20.65	-0.10	-11.33	3.35	4.61	-44.34	-216.43	-1,401.43	0.00
Operating Cash Flow to Interest Expense	-4.17	4.05	39.80	9.23	5.68	7.04	7.20	7.23	1,128.05	550.41	0.00
Operating Cash Flow Less CapEx to Interest Expense	-5.79	2.80	35.57	7.08	4.72	6.42	6.65	6.52	1,046.20	520.45	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.61	1.00	0.86	0.55	0.44	0.49	0.67	1.02	1.28	1.02
Accounts Receivable Turnover	2.82	4.06	7.71	9.54	8.12	5.77	6.13	7.21	8.35	9.86	6.90
Inventory Turnover	1.74	2.36	3.22	3.46	4.11	4.08	3.70	5.31	5.35	6.69	4.90
Fixed Asset Turnover	5.73	9.53	16.01	17.78	17.07	18.12	18.75	19.46	18.29	17.51	14.83
Accounts Payable Turnover	6.26	6.83	7.74	9.25	11.51	10.30	10.84	17.92	24.01	20.86	6.81
Days Sales Outstanding (DSO)	129.63	89.92	47.36	38.28	44.94	63.24	59.53	50.62	43.71	37.02	52.90
Days Inventory Outstanding (DIO)	209.48	154.53	113.36	105.64	88.81	89.42	98.56	68.77	68.25	54.52	74.53
Days Payable Outstanding (DPO)	58.28	53.47	47.15	39.45	31.72	35.44	33.69	20.36	15.20	17.50	53.57
Cash Conversion Cycle (CCC)	280.83	190.98	113.57	104.46	102.04	117.22	124.41	99.02	96.76	74.04	73.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	520	620	591	664	605	529	582	661	216	132	23
Invested Capital Turnover	0.63	1.14	1.79	1.41	0.84	0.57	0.62	0.96	2.23	3.87	11.50
Increase / (Decrease) in Invested Capital	-101	29	-72	59	76	-53	-79	445	83	110	23
Enterprise Value (EV)	1,672	1,873	2,582	5,961	3,047	1,632	1,396	2,043	1,271	777	197
Market Capitalization	1,669	1,939	2,667	5,785	2,832	1,519	1,214	1,769	1,407	907	276
Book Value per Share	$6.12	$8.41	$8.61	$6.38	$5.27	$5.80	$5.80	$5.79	$5.46	$4.27	$2.66
Tangible Book Value per Share	$1.69	$3.61	$3.31	$0.39	($1.60)	($0.16)	($1.21)	($2.47)	$2.67	$2.63	$2.27
Total Capital	639	809	798	795	755	622	656	735	352	263	99
Total Debt	123	122	122	306	364	207	256	348	0.00	0.00	0.00
Total Long-Term Debt	123	122	122	306	364	207	256	348	0.00	0.00	0.00
Net Debt	3.42	-66	-85	175	215	114	182	274	-136	-130	-79
Capital Expenditures (CapEx)	18	13	41	39	12	6.89	7.83	7.44	8.51	3.00	8.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	22	78	15	66	-21	22	36	52	29	23	-1.43
Debt-free Net Working Capital (DFNWC)	141	266	222	197	128	115	110	125	158	134	68
Net Working Capital (NWC)	141	266	222	197	128	115	110	125	158	134	68
Net Nonoperating Expense (NNE)	89	46	4.34	15	28	4.46	13	-5.98	-0.61	-11	0.84
Net Nonoperating Obligations (NNO)	3.39	-66	-85	174	214	114	182	273	-137	-130	-76
Total Depreciation and Amortization (D&A)	57	74	83	95	79	68	80	93	33	55	5.83
Debt-free, Cash-free Net Working Capital to Revenue	5.99%	11.19%	1.35%	7.40%	-4.38%	6.98%	9.42%	12.27%	7.40%	7.63%	-1.07%
Debt-free Net Working Capital to Revenue	39.15%	38.35%	19.82%	22.04%	26.76%	36.32%	28.58%	29.72%	40.82%	44.67%	50.84%
Net Working Capital to Revenue	39.15%	38.35%	19.82%	22.04%	26.76%	36.32%	28.58%	29.72%	40.82%	44.67%	50.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.93)	($0.91)	$1.60	$0.55	($1.35)	($0.28)	($0.38)	($0.14)	$0.96	($0.79)	($0.19)
Adjusted Weighted Average Basic Shares Outstanding	83.60M	80.72M	78.04M	76.04M	73.13M	71.01M	68.49M	66.25M	63.78M	53.38M	36.47M
Adjusted Diluted Earnings per Share	($2.93)	($0.91)	$1.55	$0.53	($1.35)	($0.28)	($0.38)	($0.14)	$0.91	($0.79)	($0.19)
Adjusted Weighted Average Diluted Shares Outstanding	83.60M	80.72M	80.85M	79.68M	73.13M	71.01M	68.49M	66.25M	67.65M	53.38M	36.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	84.63M	81.93M	78.75M	76.78M	74.54M	71.95M	69.56M	67.41M	65.11M	62.42M	37.97M
Normalized Net Operating Profit after Tax (NOPAT)	-118	-11	133	59	-68	-14	-9.14	-7.10	65	-21	-6.20
Normalized NOPAT Margin	-32.76%	-1.62%	11.87%	6.63%	-14.22%	-4.29%	-2.37%	-1.69%	16.82%	-6.89%	-4.66%
Pre Tax Income Margin	-66.21%	-9.20%	15.55%	5.36%	-24.00%	-10.24%	-8.53%	-8.09%	16.42%	-14.28%	-6.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-21.54	-5.53	18.81	3.62	-7.90	-1.99	-1.31	-2.30	607.90	-423.38	0.00
NOPAT to Interest Expense	-14.38	-2.50	13.25	3.14	-5.47	-1.39	-0.94	-1.46	583.51	-305.54	0.00
EBIT Less CapEx to Interest Expense	-23.17	-6.79	14.59	1.47	-8.86	-2.61	-1.86	-3.02	526.06	-453.34	0.00
NOPAT Less CapEx to Interest Expense	-16.00	-3.76	9.02	0.99	-6.43	-2.01	-1.49	-2.18	501.66	-335.50	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	25.20%	56.11%	0.00%	0.00%	0.00%	-3.64%	0.00%	-4.03%	0.00%

This table displays calculated financial ratios and metrics derived from MaxLinear's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.70%	-26.47%	-40.16%	-49.99%	-61.65%	-56.86%	-52.57%	-34.31%	-5.87%	17.22%	24.35%
EBITDA Growth	36.03%	-10.70%	-200.86%	-271.86%	-219.50%	-138.87%	-134.50%	-76.96%	-34.88%	11.97%	39.94%
EBIT Growth	35.28%	5.89%	-101.03%	-894.38%	-371.52%	-196.66%	-185.81%	-108.82%	-43.09%	39.19%	99.50%
NOPAT Growth	38.23%	1.37%	-274.58%	-587.55%	-604.15%	-192.99%	-137.69%	-114.62%	-71.13%	8.26%	216.48%
Net Income Growth	31.25%	-50.23%	-90.28%	-802.46%	-858.51%	-223.87%	-240.20%	-113.61%	-71.62%	10.31%	206.85%
EPS Growth	34.09%	-38.78%	-83.67%	-840.00%	-833.33%	-228.95%	-240.00%	-112.50%	-71.43%	8.57%	191.67%
Operating Cash Flow Growth	-171.38%	-67.97%	-140.24%	-108.82%	-62.12%	-123.90%	-120.71%	-75.23%	-68.58%	332.59%	-26.54%
Free Cash Flow Firm Growth	165.26%	223.24%	193.77%	185.41%	-64.80%	-156.13%	-180.73%	-147.91%	182.24%	446.93%	-14.67%
Invested Capital Growth	-9.75%	-16.22%	-14.77%	-10.96%	-9.69%	4.91%	6.09%	7.28%	-2.23%	-10.90%	-4.34%
Revenue Q/Q Growth	4.09%	13.64%	-11.84%	-3.44%	-24.00%	-7.51%	-26.32%	-25.96%	-14.50%	1.70%	2.04%
EBITDA Q/Q Growth	-33.23%	61.00%	-162.02%	53.01%	-130.55%	-5.99%	-249.67%	-67.33%	-25.00%	-5.94%	-0.03%
EBIT Q/Q Growth	-21.25%	52.07%	-101.27%	44.67%	-76.33%	-2.38%	-895.56%	-115.11%	-37.22%	-9.12%	2.29%
NOPAT Q/Q Growth	-11.95%	38.31%	-63.51%	45.29%	-78.75%	-134.27%	-200.12%	-140.11%	-67.03%	-5.05%	16.38%
Net Income Q/Q Growth	14.05%	23.68%	-93.00%	45.70%	-87.82%	3.34%	-815.40%	-145.64%	-69.33%	9.41%	-11.13%
EPS Q/Q Growth	14.71%	24.44%	-91.49%	46.59%	-79.59%	0.00%	-880.00%	-141.67%	-68.42%	8.57%	-12.50%
Operating Cash Flow Q/Q Growth	59.05%	9.41%	-1,039.87%	-116.88%	196.36%	-29.56%	-141.83%	-27.47%	-39.21%	12.29%	-49.96%
Free Cash Flow Firm Q/Q Growth	-67.88%	58.85%	14.11%	355.65%	114.92%	-20.86%	-3.93%	-287.78%	-76.20%	73.83%	-38.32%
Invested Capital Q/Q Growth	-1.43%	-1.99%	-4.26%	-2.43%	-8.50%	-0.30%	0.02%	-1.04%	6.30%	0.83%	1.15%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.11%	55.60%	54.35%	54.56%	51.71%	54.68%	54.56%	55.93%	56.47%	56.21%	58.62%
EBITDA Margin	-37.22%	-29.08%	-84.73%	-28.51%	-58.58%	-19.31%	-16.85%	8.30%	18.80%	21.43%	23.17%
Operating Margin	-48.05%	-44.67%	-82.30%	-44.37%	-78.32%	-33.30%	-13.15%	-3.23%	10.98%	14.16%	18.18%
EBIT Margin	-49.37%	-42.38%	-100.49%	-44.02%	-76.82%	-33.11%	-29.91%	-2.21%	10.85%	14.78%	16.53%
Profit (Net Income) Margin	-51.82%	-62.75%	-93.44%	-42.69%	-75.90%	-30.71%	-29.39%	-2.37%	3.84%	10.70%	9.94%
Tax Burden Percent	101.45%	141.68%	91.86%	95.02%	97.62%	90.31%	95.93%	91.41%	37.98%	76.34%	63.70%
Interest Burden Percent	103.46%	104.51%	101.23%	102.06%	101.21%	102.72%	102.42%	116.90%	93.12%	94.82%	94.39%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	62.02%	23.66%	36.30%
Return on Invested Capital (ROIC)	-22.50%	-19.78%	-39.36%	-23.68%	-49.51%	-26.68%	-13.07%	-3.79%	7.25%	19.31%	20.81%
ROIC Less NNEP Spread (ROIC-NNEP)	45.50%	72.94%	14.86%	-12.27%	-26.70%	-14.39%	36.66%	-3.45%	-10.38%	18.54%	13.37%
Return on Net Nonoperating Assets (RNNOA)	-2.06%	-3.80%	-1.27%	1.69%	3.42%	1.60%	-3.06%	0.30%	-0.08%	1.42%	1.57%
Return on Equity (ROE)	-24.56%	-23.58%	-40.63%	-21.99%	-46.09%	-25.08%	-16.13%	-3.49%	7.17%	20.73%	22.38%
Cash Return on Invested Capital (CROIC)	-15.01%	-9.78%	-11.25%	-9.24%	-6.21%	-9.21%	-7.26%	4.63%	18.67%	32.15%	25.61%
Operating Return on Assets (OROA)	-18.91%	-15.71%	-39.58%	-18.48%	-37.22%	-20.31%	-22.46%	-1.91%	10.43%	14.84%	15.93%
Return on Assets (ROA)	-19.85%	-23.27%	-36.81%	-17.92%	-36.78%	-18.84%	-22.07%	-2.04%	3.69%	10.74%	9.58%
Return on Common Equity (ROCE)	-24.56%	-23.58%	-40.63%	-21.99%	-46.09%	-25.08%	-16.13%	-3.49%	7.17%	20.73%	22.38%
Return on Equity Simple (ROE_SIMPLE)	-45.14%	0.00%	-40.56%	-30.77%	-24.29%	0.00%	-0.51%	8.67%	13.76%	0.00%	19.83%
Net Operating Profit after Tax (NOPAT)	-32	-29	-47	-29	-52	-29	-12	-4.16	10	31	33
NOPAT Margin	-33.63%	-31.27%	-57.61%	-31.06%	-54.83%	-23.31%	-9.20%	-2.26%	4.17%	10.81%	11.58%
Net Nonoperating Expense Percent (NNEP)	-68.00%	-92.72%	-54.23%	-11.40%	-22.81%	-12.28%	-49.73%	-0.34%	17.63%	0.77%	7.44%
Return On Investment Capital (ROIC_SIMPLE)	-5.24%	-4.51%	-	-	-	-3.61%	-	-	-	3.94%	-
Cost of Revenue to Revenue	43.89%	44.40%	45.65%	45.44%	48.29%	45.32%	45.44%	44.07%	43.53%	43.79%	41.38%
SG&A Expenses to Revenue	38.14%	41.32%	37.18%	36.53%	38.30%	27.43%	18.74%	18.33%	15.56%	15.30%	13.46%
R&D to Revenue	57.81%	55.64%	64.86%	61.46%	67.98%	52.05%	48.92%	38.41%	27.09%	25.37%	26.75%
Operating Expenses to Revenue	104.16%	100.28%	136.65%	98.93%	130.04%	87.98%	67.71%	59.16%	45.50%	42.05%	40.44%
Earnings before Interest and Taxes (EBIT)	-47	-39	-81	-40	-73	-42	-41	-4.07	27	43	47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-36	-27	-69	-26	-56	-24	-23	15	47	62	66
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.86	3.23	2.18	2.71	2.39	2.83	2.57	3.38	3.78	3.94	4.15
Price to Tangible Book Value (P/TBV)	7.47	11.69	6.74	7.07	5.98	6.59	5.98	7.50	8.70	10.25	13.66
Price to Revenue (P/Rev)	2.54	4.63	3.09	3.74	2.82	2.80	2.10	2.50	2.51	2.38	2.37
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	39.03	27.46	21.33	20.92
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.56%	3.64%	4.69%	4.78%
Enterprise Value to Invested Capital (EV/IC)	1.83	3.22	2.24	2.91	2.56	3.02	2.77	3.86	4.24	4.37	4.31
Enterprise Value to Revenue (EV/Rev)	2.60	4.64	3.02	3.59	2.69	2.70	2.01	2.38	2.41	2.31	2.34
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	125.55	16.98	12.60	11.05	9.69	9.72
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	68.13	21.23	16.33	14.06	14.72
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	34.26	25.56	19.96	19.89
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	84.52	43.18	13.32	11.77	8.99	6.64	7.53
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	86.20	22.47	12.80	16.44
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.25	0.24	0.22	0.20	0.19	0.18	0.17	0.16	0.17	0.18	0.28
Long-Term Debt to Equity	0.25	0.24	0.22	0.20	0.19	0.18	0.17	0.16	0.17	0.18	0.28
Financial Leverage	-0.05	-0.05	-0.09	-0.14	-0.13	-0.11	-0.08	-0.09	0.01	0.08	0.12
Leverage Ratio	1.67	1.62	1.59	1.57	1.62	1.66	1.73	1.78	1.82	1.91	2.08
Compound Leverage Factor	1.73	1.69	1.61	1.60	1.64	1.70	1.78	2.08	1.70	1.81	1.97
Debt to Total Capital	19.98%	19.24%	18.07%	16.58%	16.11%	15.13%	14.82%	14.06%	14.24%	15.26%	21.79%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.98%	19.24%	18.07%	16.58%	16.11%	15.13%	14.82%	14.06%	14.24%	15.26%	21.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	80.02%	80.76%	81.93%	83.42%	83.89%	84.87%	85.18%	85.94%	85.76%	84.74%	78.21%
Debt to EBITDA	-0.78	-0.69	-0.70	-0.95	-1.40	8.20	1.21	0.64	0.51	0.46	0.66
Net Debt to EBITDA	-0.12	-0.02	0.15	0.49	0.80	-4.42	-0.79	-0.65	-0.44	-0.32	-0.11
Long-Term Debt to EBITDA	-0.78	-0.69	-0.70	-0.95	-1.40	8.20	1.21	0.64	0.51	0.46	0.66
Debt to NOPAT	-0.90	-0.79	-0.78	-1.00	-1.25	-4.57	-14.98	1.74	1.17	0.94	1.35
Net Debt to NOPAT	-0.14	-0.02	0.17	0.52	0.72	2.47	9.87	-1.77	-1.01	-0.66	-0.23
Long-Term Debt to NOPAT	-0.90	-0.79	-0.78	-1.00	-1.25	-4.57	-14.98	1.74	1.17	0.94	1.35
Altman Z-Score	1.26	2.75	2.03	3.07	2.61	3.61	3.55	4.78	4.83	4.42	3.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.77	1.95	2.09	1.99	2.20	2.18	2.29	1.98	1.65	1.60
Quick Ratio	1.02	1.12	1.16	1.42	1.42	1.61	1.55	1.66	1.38	1.10	1.08
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	23	72	45	40	8.69	-58	-48	-46	25	104	60
Operating Cash Flow to CapEx	-573.15%	-1,269.40%	-743.73%	-89.48%	191.44%	-1,300.86%	-663.83%	607.07%	808.26%	417.11%	677.33%
Free Cash Flow to Firm to Interest Expense	9.21	25.62	17.02	14.64	3.21	-20.02	-17.75	-17.90	9.93	45.28	22.02
Operating Cash Flow to Interest Expense	-4.55	-9.94	-11.57	-1.00	5.89	-5.70	-4.71	11.80	16.95	30.26	22.78
Operating Cash Flow Less CapEx to Interest Expense	-5.35	-10.72	-13.13	-2.11	2.81	-6.14	-5.42	9.86	14.85	23.01	19.42
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.37	0.39	0.42	0.48	0.61	0.75	0.86	0.96	1.00	0.96
Accounts Receivable Turnover	3.21	2.82	3.82	3.72	3.43	4.06	5.11	6.89	7.03	7.71	7.56
Inventory Turnover	1.78	1.74	1.72	1.87	2.00	2.36	2.69	3.19	3.25	3.22	3.06
Fixed Asset Turnover	5.83	5.73	5.92	6.44	7.40	9.53	12.57	14.62	16.04	16.01	17.94
Accounts Payable Turnover	6.38	6.26	4.79	5.06	5.64	6.83	5.56	7.30	8.18	7.74	5.82
Days Sales Outstanding (DSO)	113.76	129.63	95.56	98.05	106.43	89.92	71.49	52.99	51.94	47.36	48.26
Days Inventory Outstanding (DIO)	205.37	209.48	212.00	195.50	182.68	154.53	135.61	114.44	112.24	113.36	119.13
Days Payable Outstanding (DPO)	57.22	58.28	76.19	72.16	64.66	53.47	65.68	49.98	44.64	47.15	62.74
Cash Conversion Cycle (CCC)	261.91	280.83	231.38	221.39	224.45	190.98	141.43	117.46	119.54	113.57	104.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	512	520	530	554	568	620	622	622	629	591	586
Invested Capital Turnover	0.67	0.63	0.68	0.76	0.90	1.14	1.42	1.68	1.74	1.79	1.80
Increase / (Decrease) in Invested Capital	-55	-101	-92	-68	-61	29	36	42	-14	-72	-27
Enterprise Value (EV)	938	1,672	1,188	1,611	1,452	1,873	1,722	2,400	2,667	2,582	2,526
Market Capitalization	919	1,669	1,215	1,674	1,523	1,939	1,803	2,524	2,773	2,667	2,555
Book Value per Share	$5.83	$6.12	$6.64	$7.43	$7.75	$8.41	$8.67	$9.33	$9.32	$8.61	$7.86
Tangible Book Value per Share	$1.45	$1.69	$2.15	$2.85	$3.09	$3.61	$3.72	$4.21	$4.05	$3.31	$2.39
Total Capital	616	639	680	740	761	809	825	868	856	798	787
Total Debt	123	123	123	123	123	122	122	122	122	122	172
Total Long-Term Debt	123	123	123	123	123	122	122	122	122	122	172
Net Debt	19	3.42	-27	-63	-70	-66	-81	-124	-106	-85	-29
Capital Expenditures (CapEx)	1.99	2.19	4.13	3.01	8.34	1.27	1.93	5.04	5.22	17	9.12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	19	22	10	21	28	78	73	67	66	15	11
Debt-free Net Working Capital (DFNWC)	124	141	160	207	221	266	276	313	293	222	212
Net Working Capital (NWC)	124	141	160	207	221	266	276	313	293	222	212
Net Nonoperating Expense (NNE)	17	29	29	11	20	9.28	27	0.20	0.83	0.34	4.68
Net Nonoperating Obligations (NNO)	19	3.39	-27	-63	-70	-66	-81	-124	-106	-85	-29
Total Depreciation and Amortization (D&A)	12	12	13	14	17	17	18	19	20	19	19
Debt-free, Cash-free Net Working Capital to Revenue	5.39%	5.99%	2.59%	4.73%	5.17%	11.19%	8.50%	6.61%	5.97%	1.35%	0.98%
Debt-free Net Working Capital to Revenue	34.20%	39.15%	40.55%	46.26%	40.89%	38.35%	32.11%	31.01%	26.56%	19.82%	19.64%
Net Working Capital to Revenue	34.20%	39.15%	40.55%	46.26%	40.89%	38.35%	32.11%	31.01%	26.56%	19.82%	19.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.58)	($0.68)	($0.90)	($0.47)	($0.88)	($0.49)	($0.49)	($0.05)	$0.12	$0.39	$0.36
Adjusted Weighted Average Basic Shares Outstanding	85.27M	83.60M	84.07M	83.48M	82.35M	80.72M	81.25M	80.45M	79.47M	78.04M	78.44M
Adjusted Diluted Earnings per Share	($0.58)	($0.68)	($0.90)	($0.47)	($0.88)	($0.49)	($0.49)	($0.05)	$0.12	$0.38	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	85.27M	83.60M	84.07M	83.48M	82.35M	80.72M	81.25M	80.45M	81.34M	80.85M	80.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	86.37M	84.63M	84.36M	83.90M	83.13M	81.93M	81.56M	81.02M	79.98M	78.75M	78.57M
Normalized Net Operating Profit after Tax (NOPAT)	-27	-27	-27	-28	-36	-22	-12	-1.05	24	34	33
Normalized NOPAT Margin	-27.88%	-28.95%	-33.38%	-30.40%	-38.20%	-17.36%	-9.17%	-0.57%	9.68%	11.86%	11.72%
Pre Tax Income Margin	-51.08%	-44.29%	-101.72%	-44.92%	-77.75%	-34.01%	-30.63%	-2.59%	10.10%	14.01%	15.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-18.91	-13.94	-30.70	-14.96	-26.99	-14.27	-14.93	-1.57	10.84	18.73	17.43
NOPAT to Interest Expense	-12.89	-10.29	-17.60	-10.56	-19.27	-10.04	-4.59	-1.60	4.17	13.71	12.21
EBIT Less CapEx to Interest Expense	-19.71	-14.72	-32.25	-16.08	-30.07	-14.71	-15.64	-3.52	8.74	11.48	14.06
NOPAT Less CapEx to Interest Expense	-13.68	-11.07	-19.15	-11.67	-22.34	-10.48	-5.30	-3.55	2.07	6.45	8.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	25.20%	38.41%

Frequently Asked Questions About MaxLinear's Financials

When does MaxLinear's financial year end?

According to the most recent income statement we have on file, MaxLinear's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MaxLinear's net income changed over the last 10 years?

MaxLinear's net income appears to be on an upward trend, with a most recent value of -$245.20 million in 2024, rising from -$7.04 million in 2014. The previous period was -$73.15 million in 2023. See where experts think MaxLinear is headed by visiting MaxLinear's forecast page.

What is MaxLinear's operating income?

MaxLinear's total operating income in 2024 was -$223.35 million, based on the following breakdown:

Total Gross Profit: $194.78 million
Total Operating Expenses: $418.13 million

How has MaxLinear revenue changed over the last 10 years?

Over the last 10 years, MaxLinear's total revenue changed from $133.11 million in 2014 to $360.53 million in 2024, a change of 170.8%.

How much debt does MaxLinear have?

MaxLinear's total liabilities were at $348.36 million at the end of 2024, a 11.6% decrease from 2023, and a 851.6% increase since 2014.

How much cash does MaxLinear have?

In the past 10 years, MaxLinear's cash and equivalents has ranged from $20.70 million in 2014 to $187.35 million in 2022, and is currently $118.58 million as of their latest financial filing in 2024.

How has MaxLinear's book value per share changed over the last 10 years?

Over the last 10 years, MaxLinear's book value per share changed from 2.66 in 2014 to 6.12 in 2024, a change of 130.2%.

Related Companies

This page (NASDAQ:MXL) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MaxLinear (MXL) Financials

Frequently Asked Questions About MaxLinear's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MaxLinear (MXL) Financials

Annual Income Statements for MaxLinear

Quarterly Income Statements for MaxLinear

Annual Cash Flow Statements for MaxLinear

Quarterly Cash Flow Statements for MaxLinear

Annual Balance Sheets for MaxLinear

Quarterly Balance Sheets for MaxLinear

Annual Metrics And Ratios for MaxLinear

Quarterly Metrics And Ratios for MaxLinear

Frequently Asked Questions About MaxLinear's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools